https://investor.ironwoodpharma.com/press-releases/press-release-details/2015/Ironwood-Pharmaceuticals-Announces-Proposed-Offering-of-300-Million-of-Convertible-Senior-Notes/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- June 8, 2015